Vuba aha, Ikigo cy’Igihugu gishinzwe Ibikoresho by’Ubuvuzi mu Bushinwa (NMPA) cyemeye Enhertu guterwa inshinge zo kuvura ubwoko bwihariye bw’abarwayi ba kanseri y’ibere iteye imbere, bigaragaza iterambere rikomeye mu kurwanya kanseri y’ibere ku isi. Uku kwemezwa gushingiye ku bisubizo byiza by’igerageza rya DESTINY-Breast06, bigaragaza iterambere rikomeye mu kuvura neza imisemburo itera kanseri,
Ku ya 25 Ukuboza 2025, NMPA yemeje ku mugaragaro Enhertu mu kuvura abarwayi ba kanseri y'ibere bakuru bafite ubumuga bwo kudakira cyangwa ubumuga bwo kugabanuka kw'imisemburo, ubumuga bwo kugabanuka cyangwa ubumuga bwo kugabanuka cyane bw'imisemburo ya HER2, bateye imbere nyuma yo kuvurwa mbere mu buryo bwa endocrine mu gihe cy'uburwayi bwo kugabanuka. Porofeseri Hu Xichun, Impuguke Nkuru mu Ishami ry'Ubuvuzi bw'Imbere muri Kaminuza ya Fudan Shanghai Cancer Center, yagize ati: “Ibisubizo by'ubushakashatsi bwa DESTINY-Breast06 bitanga ibimenyetso bya mbere byerekana ko uburyo bwo kuvura bukoresheje ikoranabuhanga bushobora gufasha aba barwayi batari basanzwe bafite serivisi nziza, ibyo bikaba bifite akamaro kanini mu bya siyansi. Hamwe n'ubu bwemere, abarwayi benshi ba kanseri y'ibere bafite ubumuga bwo kugabanuka kw'imisemburo ya HER2 bazagira amahirwe yo kungukirwa n'imiti ya ADC.”
Amakuru y’igeragezwa ry’ubuvuzi arashimishije: ku barwayi ba kanseri y’ibere bafite HR kandi bafite HER2-low metastasis batari barahawe chemotherapy mbere, Enhertu yagabanyije ibyago byo gukomeza indwara cyangwa gupfa ku kigero cya 38% ugereranije na chemotherapy. Ikigaragara kurushaho, igipimo cy’ubwitabire bwageze kuri 56.5% ku barwayi bafite HER2-low ndetse no ku kigero cya 61.8% ku bantu bafite HER2-low expression, byombi bikaba biri hejuru cyane ugereranyije n’itsinda rya chemotherapy.
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing: Guhuza Abarwayi bo ku Isi n’Ubuvuzi Buhanitse
Nk'imwe mu mavuriro y'ingenzi mu Bushinwa avura kanseri, Ishami Mpuzamahanga ry'Ibitaro Mpuzamahanga bya Beijing mu Karere k'Amajyepfo ryiyemeje guha abarwayi bo ku isi uburyo bwo kuvura kanseri bugezweho ndetse na serivisi z'ubuvuzi zihariye. Dukurikiranira hafi iterambere mpuzamahanga ry'ubuvuzi kugira ngo abarwayi babone uburyo bushya bwo kuvura kanseri vuba.
Itsinda ryacu mpuzamahanga ry’abaganga rigizwe n’inzobere mu buvuzi bwa kanseri, batari abahanga mu ikoranabuhanga rigezweho ryo kuvura gusa, ahubwo banafite ubumenyi mu itumanaho mu ndimi nyinshi, bigatuma bashobora gutanga ubufasha busesuye na serivisi z’ubuvuzi ku barwayi mpuzamahanga.
Uburyo bworoshye bwo gushyikirana: Uburyo bwinshi bwo kugisha inama
Dusobanukiwe n'ibikenewe byihutirwa ku barwayi mpuzamahanga bashaka ubufasha bw'ubuvuzi, bityo dutanga uburyo butandukanye bworoshye bwo guhamagara:
Gutanga inama kuri telefoni: Nyamuneka hamagara umurongo mpuzamahanga w’ubuvuzi ku barwayi kuri 400-880-3716. Abahuzabikorwa bacu b’abaganga b’inzobere bazaguha inama n’ubuyobozi birambuye.
Twandikire kuri WeChat: Ongeraho konti yacu yemewe ya WeChat kuri 17801183037 kugira ngo uvugane n'umujyanama w'ubuvuzi mu buryo butaziguye binyuze mu butumwa bugufi, ijwi, cyangwa videwo.
Imeri:
- Send inquiries to 100085_010@163.com
- Or contact myimmnet@163.com
Itsinda ryacu rizasubiza ubutumwa bwawe mu masaha 24, riguhe amakuru arambuye y'ubuvuzi, kwiyandikisha mu bitaro, gahunda z'inzobere, n'izindi serivisi.
Serivisi zuzuye z'abarwayi mpuzamahanga
Ishami Mpuzamahanga ry’Ibitaro bya Oncology byo mu Karere k’Amajyepfo rya Beijing ritanga serivisi zo guhagarara ku barwayi mpuzamahanga, harimo:
- Ubujyanama bw'abahanga n'inama zo kure
- Isuzuma n'uburyo bwo kuvura
- Gahunda yo kujya mu bitaro no gutanga ubufasha ku bijyanye na viza yo kwa muganga
- Ubufasha mu guhindura ururimi no guhuza umuco
- Amabwiriza ku bijyanye n'aho umuntu aba mu gihe cyo kuvurwa
Turasobanukiwe cyane ko urugendo rwa buri murwayi ari umwihariko. Kubwibyo, twiyemeje gutanga serivisi z’ubuvuzi zihariye kandi zirangwa n’ubuntu kugira ngo twizere ko mwitaho kandi mushyigikiwe n’ababigize umwuga mu gihe cyo kuvurwa kwanyu.
Fata ingamba: Shaka inama ku buryo bwihariye zo kuvura
Niba wowe cyangwa abakunzi bawe muhanganye n'ibibazo mu kuvura kanseri y'ibere, cyane cyane kanseri y'ibere iteye imbere ifite ubumuga bwa HR-positive, HER2-low cyangwa ultra-low expression, iki ni cyo gihe cyo gushaka inama z'abaganga b'inzobere. Kwemerwa kwa Enhertu bizana icyizere gishya kuri iri tsinda ry'abarwayi.
Twandikire ako kanya ukoresheje uburyo bukurikira:
- Hamagara 400-880-3716 kugira ngo uvugane n'umujyanama w'ubuvuzi mu buryo butaziguye
- Ongeraho WeChat 17801183037 kugira ngo ubone inama ako kanya
- Send an email to 100085_010@163.com or myimmnet@163.com with a detailed description of the condition
Itsinda ryacu ry’abaganga mpuzamahanga rizatanga inama z’inzobere mu kuvura no gutegura ubuvuzi bushingiye ku kibazo cyawe. Muri Beijing South Region Oncology Hospital International Department, twizera ko umurwayi wese akwiye kubona ubuvuzi bugezweho kandi bukwiye. Twiteguye kugufasha mu nzira yo gukira.
Igihe cyo kohereza: Mutarama-08-2026